PAO (PK) News
PAOG
PAO (PK) News
1
Follow PAOG
0.0033
0.00005 (1.5%) Upgrade to Real-Time
Market Open
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
January 13 2021 - 11:22AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Sandusky, OH -- January 13, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced the upcoming update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook scheduled for tomorrow, Thursday Jan 14th, 2021, will include an update on the planned PAOG stock dividend to shareholders of Puration, Inc. (USOTC: PURA) in conjunction with PAOG’s acquisition of hemp cultivation business from PURA.
In 2020, PAOG acquired a hemp cultivation business from PURA and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
PAOG recently announced a key contract with a Contract Research Organization (CRO) to advance the company’s RespRx formula through the process to becoming an approved pharmaceutical treatment.
The company also recently confirmed that the company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020.
Look for the update this Thursday to learn more.
Learn more about PAOG at www.paogroupinc.com.
News 
Market Data 
Discover 
